Skip to main content
Clinical Trials/IRCT138904144316N1
IRCT138904144316N1Completed未知

Comparison of the efficacy and adverse effects of visipaque and Ultravist in Contrast-enhanced CT Scan

Vice chancellor for research, Hamedan University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • Inclusion criteria : patients reffered for abdomenoplevic CT
  • Exclusion criteria : renal disease, Diabetes, known drug reaction

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Hamedan University of Medical Sciences

Similar Trials